Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 48.08
-1.01 (-2.06%)
At close: Jan 22, 2026
Hinova Pharmaceuticals Revenue
Hinova Pharmaceuticals had revenue of 10.18M CNY in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 23.61M, up 21,414.67% year-over-year. In the year 2024, Hinova Pharmaceuticals had annual revenue of 366.84K.
Revenue (ttm)
23.61M
Revenue Growth
+21,414.67%
P/S Ratio
201.65
Revenue / Employee
135.68K
Employees
174
Market Cap
4.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 366.84K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.65M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hefei Lifeon Pharmaceutical | 1.47B |
| Beijing Kawin Technology Share-Holding | 1.15B |
| Pulike Biological Engineering | 1.10B |
| ChemPartner PharmaTech | 1.07B |
| Beijing Bohui Innovation Biotechnology Group | 834.38M |
| Assure Tech (Hangzhou) | 462.72M |
| Innovita Biological Technology | 430.96M |
| Guanhao Biotech | 392.83M |